The immune modulation of Bacillus cereus var. Toyoi in mice immunized with experimental inactivated Bovine Herpesvirus Type 5 vaccine

Vaccine

Volumn 30, Issue 12, 2012, Pages 2173-2177

  Roos, Talita Bandeira ^a   de Lara, Ana Paula de Souza Stori ^a   Dummer, Luana Alves ^a   Fischer, Geferson ^a   Leite, Fábio Pereira Leivas ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Cytokine; Immune modulation; Probiotic; Vaccine

Indexed keywords

BOVINE HERPESVIRUS TYPE 5 VACCINE; GAMMA INTERFERON; HERPES VACCINE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACILLUS CEREUS; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SUPPLEMENTATION; TH1 CELL; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BACILLUS CEREUS; FEMALE; GENE EXPRESSION; HERPESVIRUS 5, BOVINE; HERPESVIRUS VACCINES; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; PROBIOTICS;

EID: 84857366017     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.01.007     Document Type: Article

References (33)

1. Schrezenmeir J., De Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. American Journal of Clinical Nutrition 2001, 73:361S-364S.
2. Tomasik P.J., Tomasik P. Probiotics and prebiotics. Cereal Chemistry 2003, 80:113-117.
3. Erickson L.K., Hubbard E.N. Probiotic immunomodulation in health and disease. Journal of Nutrition 2000, 130:403-409.
4. Coppola M.M., Conceição F.R., Gil-Turnes C. Effect of Saccharomyces boulardii and Bacillus cereus var. Toyoi on the humoral and cellular response of mice to vaccines. Food and Agricultural Immunology 2005, 16:213-219.
5. Schierack P., Wieler L.H., Taras D., Herwig V., Tachu B., Hlinak A., et al. Bacillus cereus var. Toyoi enhanced systemic immune response in piglets. Veterinary Immunology and Immunopathology 2007, 118:1-11.
6. Roos T.B., Tabeleão V.C., Dummer L., Schwegler E., Goulart M.A., Moura S.V., et al. Effect of Bacillus cereus var. Toyoi and Sacharomyces boulardii on the immune response of sheep to vaccines. Food and Agricultural Immunology 2010, 21:113-118.
7. Johnston L.A.Y., Simmons G.C., McGavin M.D. A viral meningoencephalitis in calves. Australian Veterinary Journal 1962, 38:207-215.
8. Salvador S., Lemos R., Riet-Correa F., Roehe P., Osório A. Meningoencefalite em bovinos causada por herpesvírus bovino-5 no Mato Grosso do Sul e São Paulo. Pesquisa Veterinária Brasileira 1998, 18:76-83.
9. Bartha A., Hadju G., áldásy P., Paczolay G. Occurrence of encephalitis caused by infectious bovine rhinotracheitis virus in calves in Hungary. Acta Veterinaria Academiae Scientiarum Hungaricae 1969, 19:145-151.
10. D'offay J.M., Mock R.E., Fulton R.W. Isolation and characterization of encephalitic bovine herpesvirus type 1 isolates from cattle in North America. American Journal of Veterinary Research 1993, 54:534-539.
11. Del Médico Zajac M.P., Ladelfa M.F., Kotsias F., Muylkens B., Thiry J., Thiry E., et al. Review: biology of bovine herpesvirus 5. The Veterinary Journal 2010, 184:138-145.
12. Del Médico Zajac M.P., Puntel M., Zamorano P.I., Sadir A.M., Romera S.A. BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle. Research in Veterinary Science 2006, 81:327-334.
13. Dummer L.A., Conceição F.R., Nizoli L.Q., Moraes C.M., Rocha A.R., Souza L.L., et al. Cloning and expression of a truncated form of envelope glycoprotein D of Bovine herpesvirus type 5 in methylotrophic yeast Pichia pastoris. Journal of Virological Methods 2009, 161:84-90.
14. Ulett G.C., Ketheesan N., Hirst R.G. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infection and Immunity 2000, 68:2034-2042.
15. SAS SAS/STAT user's guide 1997, SAS Inst. Inc., Cary, NC.
16. Plotkin S.A. Vaccines: past, present and future. Nature Medicine 2005, 11:5-11.
17. Jang M., Kweon M.N., Iwatani K., Yamamoto M., Terahara K., Sasakawa C., et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proceedings of the National Academy of Sciences 2004, 101:6110-6115.
18. Clancy R.L., Pang G. Review: probiotics - industry myth or a practical reality. Journal of the American College of Nutrition 2007, 26:691-694.
19. Jain S., Yadav H., Sinha P.R., Marotta F. Modulation of cytokine gene expression in spleen and Peyer's patches by feeding dahi containing probiotic Lactobacillus casei in mice. Journal of Digestive Diseases 2009, 10:49-54.
20. Li H., Nookala S., Re F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release. The Journal of Immunology 2007, 178:271-276.
21. Kaufamman S.H.E. The contribution of immunology to the rational design of novel antibacterial vaccines. Nature 2007, 5:491-504.
22. Pinto R.A., Arredondo S.M., Gaggero A.A., Diaz P.V. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection as associated with increased endogenous plasma cortisol. Pediatrics 2006, 117:878-886.
23. De Gregorio E., Tritto E., Rappuoli R. Alum adjuvanticity: unraveling a century old mystery. European Journal of Immunology 2008, 38:2068-2071.
24. Kool M., Soulli T., Van Nimwegen M., Willart M.A.M., Muskens F., Jung S., et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. The Journal of Experimental Medicine 2008, 205:869-882.
25. Asseman C., Mauze S., Leach M.W., Coffman R.L., Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. The Journal Experimental Medicine 1999, 190:995-1004.
26. Go N.F., Castle B.E., Barrett R., Kastelein R., Dang W., Mosmann T.R., et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. The Journal of Experimental Medicine 1990, 172:1625-1631.
27. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D.H., et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proceedings of the National Academy of Sciences 1992, 89:1890-1893.
28. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. The Journal of Experimental Medicine 1995, 181:839-844.
29. Mocellin S., Marincola F.M., Young H.A. Interleukin-10 and the immune response against cancer: a counterpoint. Journal of Leukocyte Biology 2005, 78:1043-1051.
30. Galdeano C.M., Perdigón G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. Journal of Applied Microbiology 2004, 94:673-681.
31. Shanahan F. Probiotics and the immune response: how much can we expect?. Journal of Pediatric Gastroenterology and Nutrition 2004, 39:748-749.
32. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annual Review of Immunology 2000, 18:217-242.
33. Vaughan E.E., Mollet B., Devos W.M. Functionality of probiotics and intestinal lactobacilli: light in the intestinal tract tunnel. Food Biotechnology 1999, 10:505-510.